PubMed HealthSearch

PubMed · 9284265

Left ventricular systolic function, arterial elastance, and ventricular-vascular coupling: a developmental study in piglets.

Abstract

Circulatory changes occur during perinatal life that increase cardiac output and left ventricular contractile reserve. To examine postnatal changes in left ventricular systolic function and ventricular-vascular coupling, piglets underwent cardiac catheterization at 1, 2, 4, and 6 wk of age. We measured end-systolic elastance (Ees), preload-recruitable stroke work, dP/dt(max), the dP/dt(max) end-diastolic volume relation, cardiac index, heart rate, arterial elastance (Ea), and the ratio Ea/Ees, at rest, during isoproterenol infusions (0.05-1.0 microg/kg/min), and after propranolol (1 mg/kg i.v.). Resting heart rate and cardiac index decreased between 1 and 6 wk. In 1 wk olds, resting Ees was at maximum and was unchanged during isoproterenol infusion; isoproterenol increased other contractility indices. Two, 4, and 6 wk olds demonstrated reserve using all contractility indices. Contractile efficiency was not different between ages. In 1 wk olds, Ea decreased during isoproterenol infusion; isoproterenol did not change Ea at 6 wk. Ea/Ees was higher at rest at 6 wk than at 1 wk, and fell significantly on isoproterenol; isoproterenol did not change Ea/Ees at 1 wk. With beta-adrenergic stimulation, 1 wk olds increased cardiac index by increasing heart rate and decreasing afterload, 6 wk olds increased cardiac index by increasing heart rate and contractility; no change in contractile efficiency was found in either group. In summary, contractile reserve is limited at 1 wk when measured by Ees, but other indices demonstrated reserve. Indexed Ea falls in response to beta-adrenergic stimulation in all ages but 6 wk. Ventricular-vascular coupling is optimized at 1 wk even under baseline conditions.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S C Cassidy, D P Chan, H D Allen. 1997. Left ventricular systolic function, arterial elastance, and ventricular-vascular coupling: a developmental study in piglets.. https://doi.org/10.1203/00006450-199709000-00005

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Adrenergic drug effects on cyclic AMP in cultured human trabecular meshwork cells.

Cyclic AMP production in the presence or absence of various adrenergic agonists and antagonists was determined in cultured human trabecular cells using a gammaflow automated radioimmunoassay that allowed multiple simultaneous experiments and reproducible results. Adrenergic agonists and antagonists showed activation and inhibition constants consistent with the presence of beta2-receptors: Ka of isoproterenol < epinephrine < norepinephrine < phenylephrine; Ki of timolol < betaxolol < celiprolol < atenolol. Selective ICI antagonists showed beta2-specificity.

Adrenergic beta-Agonists

Pre- and post-hatching developmental changes in beta-adrenoceptor subtypes in chick brain.

This study used [3H]CGP 12177 as a radioligand to determine the beta1 and beta2-adrenoceptor changes from the pre-hatching E17 stage, where the beta2 subtype is first detected, to the post-hatching P30 stage. While beta1-adrenoceptors were found to be present from E18 and were limited to cerebellum and hyperstriatum in all stages studied, beta2-adrenoceptors showed a wider distribution throughout the brain. In most of the structures analysed both beta1- and beta2-adrenoceptor binding values reached a maximum in the P2 stage, followed by a decrease over the following days. A second increase in both subtypes was detected again in the P15 and P30 stages. These results support the notion of a specific role for beta-adrenoceptors in neural plasticity in the first week after hatching and suggest that the beta2 subtype is the main adrenoceptor in chick brain throughout its development.

Adrenergic beta-Agonists

Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.

BACKGROUND: Autoantibodies directed against the beta1-adrenergic receptor have been described in patients with dilated cardiomyopathy. These autoantibodies exert an agonistic, chronotropic effect on spontaneously beating cultured neonatal rat cardiomyocytes. We studied the effect of such antibodies on beta1-adrenergic receptor expression. METHODS AND RESULTS: Cardiomyocytes were incubated with either the beta-adrenergic agonist isoproterenol or autoantibodies for 72 hours. beta-Adrenergic receptor expression was studied on the mRNA level with semiquantitative reverse transcription-polymerase chain reaction and on the protein level with immunoblotting. Isoproterenol downregulated both mRNA and beta1- and beta2-adrenergic receptor protein subtypes, whereas the anti-beta1-adrenergic receptor autoantibodies decreased only the beta1-adrenergic receptor mRNA and protein. Long-term incubation of cultured cardiomyocytes with isoproterenol or the anti-beta1-adrenergic receptor autoantibodies reduced the acute stimulatory effect of isoproterenol on the myocytes. These effects were prevented by incubating the cells with isoproterenol in the presence of propranolol or with anti-beta1-adrenergic receptor autoantibodies in the presence of bisoprolol. Bisoprolol also abolished the reduction of the beta1-adrenergic receptor expression caused by longer-term incubation with isoproterenol and the autoantibodies. CONCLUSIONS: We conclude that after longer-term treatment with the anti-beta1-adrenergic receptor autoantibodies, the rat cardiomyocytes showed a beta-adrenergic receptor expression similar to that observed in failing hearts from patients with dilated cardiomyopathy.

Adrenergic beta-Agonists